{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-044913","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2025-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.560847+00:00","generated_at":"2026-05-21T03:10:01.945954+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Silo Pharma closes $2M public offering of common stock and warrants","bullets":["Offered 3,333,338 shares (or pre-funded warrants) plus Series A-1 and A-2 warrants for up to 3,333,338 shares each.","Combined price $0.60/unit; gross proceeds ~$2M, net ~$1.56M after fees and expenses.","Series A-1 warrants exercise price $0.60, expire 5 years; Series A-2 warrants $0.60, expire 18 months from issuance.","H.C. Wainwright exclusive placement agent; received 7.5% cash fee, 1% management fee, and 250,000 warrants at $0.75.","Net proceeds to be used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-044913","json":"https://secwatch.observer/filing/0001213900-25-044913.json","markdown":"https://secwatch.observer/filing/0001213900-25-044913.md","text":"https://secwatch.observer/filing/0001213900-25-044913.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025044913/0001213900-25-044913-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025044913/ea0242442-8k_silo.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T03:10:01.945954+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}